Market research
002332.SHE Zhejiang Xianju Pharmaceutical Co.,Ltd
SHE CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9B
- P/E ratio
- 22.41
- Analyst target
- 11.345
- Dividend yield
- 3.5%
- Beta
- 0.18
Community
Investor discussion
1 comment
Sign in to join the 002332.SHE discussion.
5 years, 5 months ago
Zhejiang Xianju Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.
From a valuation standpoint, the stock is 67.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Zhejiang Xianju Pharmaceutical Co.,Ltd's total revenue rose by 23.8% to $1B since the same quarter in the previous year.
Its net income has increased by 28.1% to $153M since the same quarter in the previous year.
Finally, its free cash flow grew by 113.6% to $228M since the same quarter in the previous year.
Based on the above factors, Zhejiang Xianju Pharmaceutical Co.,Ltd gets an overall score of 4/5.